Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.19K Buy
744
+633
+570% +$3.53K ﹤0.01% 3772
2026
Q1
$434 Buy
+111
New +$493 ﹤0.01% 4451
2025
Q2
Sell
-12
Closed -$65 4235
2025
Q1
$64 Hold
12
﹤0.01% 3971
2024
Q4
$101 Buy
+12
New +$93 ﹤0.01% 4026
2022
Q4
Sell
-12
Closed -$12K 4830
2022
Q3
$12K Hold
12
﹤0.01% 3528
2022
Q2
$12K Hold
12
﹤0.01% 3273
2022
Q1
$12K Buy
+12
New +$330 ﹤0.01% 3273
2018
Q2
Sell
-20
Closed -$1K 4049
2018
Q1
$1K Hold
20
﹤0.01% 3666
2017
Q4
$1K Hold
20
﹤0.01% 3717
2017
Q3
$0 Hold
20
﹤0.01% 4202
2017
Q2
$1K Hold
20
﹤0.01% 3944
2017
Q1
$1K Hold
20
﹤0.01% 3857
2016
Q4
$0 Hold
20
﹤0.01% 4130
2016
Q3
$0 Hold
20
﹤0.01% 4035
2016
Q2
$0 Buy
+20
New +$418 ﹤0.01% 4065
2016
Q1
Sell
-121
Closed -$3K 3330
2015
Q4
$3K Buy
+121
New +$3.27K ﹤0.01% 3219

Other funds holding TBI

IFP Advisors's TBI Position: Q2 2026 in Review

IFP Advisors increased its Trueblue (TBI) stake by 570% in Q2 2026, buying an estimated $3.53K and bringing the position to 744 shares worth $5.19K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

IFP Advisors first reported a position in TBI in Q4 2015 and has held it in 16 quarters since. The position peaked at $12K in Q3 2022. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • IFP Advisors held 744 shares of Trueblue worth $5.19K as of Q2 2026.
  • IFP Advisors bought 633 Trueblue shares in Q2 2026, an estimated $3.53K.
  • Trueblue made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3772 holding.
  • IFP Advisors first reported a position in Trueblue in Q4 2015 and has held it in 16 quarters since.
  • IFP Advisors's Trueblue position peaked at $12K in Q3 2022.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.